On September 7, 2022, Pulike Biological Engineering, Inc. closed the transaction. The company has amended the terms of the transaction. The company has issued 31,420,573 shares at a price of CNY 28.58 per share for gross proceeds of CNY 897,999,976.34.

The transaction included participation from Zhang Xuke for 1,679,496 shares and CNY 47,999,995.68, Origin Asset Management Co., Ltd. for 5,388,383 shares and CNY 153,999,986.14 for 1.53% stake, Wu Zhiwei for 1,049,685 shares and CNY 29,999,997.30, Harvest Fund Management Co., Ltd. for 4,058,782 shares and CNY 115,999,989.56 for 1.15% stake, Soochow Asset Management Co., Ltd. for 1,119,664 shares and CNY 31,999,997.12, Guangxi Nongken Capital Management Group Co., Ltd for 3,149,055 shares and CNY 89,999,991.90 and for 0.89% stake, Modern Seed Industry Development Fund Co., Ltd. for 2,414,275 shares and CNY 68,999,979.50, China Nongken Industrial Development Fund (Limited Partnership) for 6,997,900 shares and CNY 199,999,982.00 and 1.98% stake, Li Haiping for 1,819,454 shares and CNY 51,999,995.32 and 1.41% stake, JPMorgan Chase Bank, National Association for 1,679,496 shares and CNY 47,999,995.68, Nanjing Iron & Steel Co., Ltd. for 1,049,685 shares and CNY 29,999,997.30, Sunshine Asset Management Co., Ltd. through Active Allocation No. 2 Asset Management Product for 1,014,698 shares and CNY 29,000,068.84. The company incurred issue fees of CNY12,179,453.12, sponsorship and underwriting fee of CNY9,979,999.76 and received net proceeds of CNY 885,820,523.22.

The shares subscribed by Zhang Xuke must not be transferred within 18 months after issuance completion and the shares subscribed by other investors must not be transferred within 6 months after the issuance completion.